Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma

Journal of Experimental Medicine

Volumn 189, Issue 10, 1999, Pages 1621-1629

  De Sanctis, George T ^a   MacLean, James A ^b   Hamada, Kaoru ^c   Mehta, Sanjay ^d   Scott, Jeremy A ^d   Jiao, Aiping ^a   Yandava, Chandri N ^a   Kobzik, Lester ^c   Wolyniec, Walter W ^e   Fabian, Attila J ^b   Venugopal, Changaram S ^a   Grasemann, Hartmut ^a   Huang, Paul L ^b   Drazen, Jeffrey M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Allergen; Asthma; Mice; Nitric oxide; Nitric oxide synthase

Indexed keywords

IMMUNOGLOBULIN E; METHACHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVALBUMIN;

AIRWAY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CALCIUM; DISEASE MODELS, ANIMAL; GENE TARGETING; HISTOCYTOCHEMISTRY; HUMANS; ISOENZYMES; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; OVALBUMIN; PLETHYSMOGRAPHY; PNEUMONIA;

EID: 0033577861     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.10.1621     Document Type: Article

References (60)

1. National Asthma Education Program. Expert Panel Report. 1991. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. J. Allergy Clin. Immunol. 88:425-534.
2. Wolyniec, W.W., G.T. De Sanctis, G. Nabozny, C. Torcellini, N. Haynes, A. Joetham, E.W. Gelfand, J.M. Drazen, and T.C. Noonan. 1998. Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-1-deficient mice. Am. J. Respir. Cell Mol. Biol. 18:777-785.
3. Padrid, P.A., M. Mathur, X. Li, K. Herrmann, Y. Qin, A. Cattamanchi, J. Weinstock, D. Elliott, A.I. Sperling, and J.A. Bluestone. 1998. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/ Th2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 18:453-462.
4. Haczku, A., K. Takeda, E. Hamelmann, A. Oshiba, J. Loader, A. Joetham, C. Irvin, H. Kikutani, and E.W. Gelfand. 1997. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am. J. Respir. Crit. Care Med. 156:1945-1955.
5. Hogan, S.P., A. Mould, H. Kikutani, A.J. Ramsay, and P.S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99:1329-1339.
6. Kung, T.T. 1998. Pulmonary eosinophilia and inflammation in allergic mice. Lab. Anim. Sci. 48:61-63.
7. De Sanctis, G.T., W.W. Wolyniec, F.H. Green, S. Qin, A. Jiao, P.W. Finn, T. Noonan, A.A. Joetham, E. Gelfand, C.M. Doerschuk, and J.M. Drazen. 1997. Reduction of allergic airway responses in P-selectin-deficient mice. J. Appl. Physiol. 83:681-687.
8. Nijkamp, F.P., and G. Folkerts. 1995. Nitric oxide and bronchial hyperresponsiveness. Arch. Int. Phamacodyn. Ther. 329: 81-96.
9. Hamid, Q., D.R. Springall, V. Riveros-Moreno, P. Chanez, P. Howarth, A. Redington, J. Bousquet, P. Godard, S. Holgate, and J.M. Polak. 1993. Induction of nitric oxide synthase in asthma. Lancet. 342:1510-1513.
10. Yeadon, M., and R. Price. 1995. Induction of calcium-independent nitric oxide synthase by allergen challenge in sensitized rat lung in vivo. Br. J. Phamacol. 116:2545-2546.
11. Renzi, P.M., N. Sebastiao, A.S. al Assaad, A. Giaid, and Q. Hamid. 1997. Inducible nitric oxide synthase mRNA and immunoreactivity in the lungs of rats eight hours after antigen challenge. Am. J. Respir. Cell Mol. Biol. 17:36-40.
12. Alving, K., E. Weitzberg, and J.M. Lundberg. 1993. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6:1368-1370.
13. Kharitonov, S.A., D. Yates, D.R. Springall, L. Buttery, J. Polak, R.A. Robbins, and P.J. Barnes. 1995. Exhaled nitric oxide is increased in asthma. Chest. 107:156S-157S. (Suppl.).
14. Massaro, A.F., S. Mehta, C.M. Lilly, L. Kobzik, J.J. Reilly, and J.M. Drazen. 1996. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am. J. Respir. Crit. Care Med. 153:1510-1514.
15. Baraldi, E., N.M. Azzolin, S. Zanconato, C. Dario, and F. Zacchello. 1997. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J. Pediatr. 131:381-385.
16. Lundberg, J.O. 1996. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Acta Physiol. Scand. Suppl. 633:1-27.
17. Silkoff, P.E., P.A. McClean, A.S. Slutsky, M. Caramori, K.R. Chapman, C. Gutierrez, and N. Zamel. 1998. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J. Asthma. 35:473-479.
18. Saleh, D., P. Ernst, S. Lim, P.J. Barnes, and A. Giaid. 1998. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12:929-937.
19. Vaali, K., L. Li, B. Redemann, I. Paakkari, and H. Vapaatalo. 1996. In-vitro bronchorelaxing effects of novel nitric oxide donors GEA 3268 and GEA 5145 in guinea-pigs and rats. J. Pharm. Phamacol. 48:1309-1314.
20. Kacmarek, R.M., R. Ripple, B.A. Cockrill, K.J. Bloch, W.M. Zapol, and D.C. Johnson. 1996. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am. J. Respir. Crit. Care Med. 153: 128-135.
21. Gwyn, D.R., K.S. Lindeman, and C.A. Hirshman. 1996. Inhaled nitric oxide attenuates bronchoconstriction in canine peripheral airways. Am. J. Respir. Crit. Care Med. 153:604-609.
22. Pfeffer, K.D., G. Ellison, D. Robertson, and R.W. Day. 1996. The effect of inhaled nitric oxide in pediatric asthma. Am. J. Respir. Crit. Care Med. 153:747-751.
23. Roger, N., J.A. Barbera, R. Farre, A. Cobos, J. Roca, and R. Rodriguez-Roisin. 1996. Effect of nitric oxide inhalation on respiratory system resistance in chronic obstructive pulmonary disease. Eur. Respir. J. 9:190-195.
24. Taylor, D.A., J.L. McGrath, B.J. O'Connor, and P.J. Barnes. 1998. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am. J. Respir. Crit. Care Med. 158:99-106.
25. Robbins, R.A., D.R. Springall, J.B. Warren, O.J. Kwon, L.D. Buttery, A.J. Wilson, I.M. Adcock, V. Riveros-Moreno, S. Moncada, J. Polak, et al. 1994. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198: 835-843.
26. Watkins, D.N., D.J. Peroni, K.A. Basclain, M.J. Garlepp, and P.J. Thompson. 1997. Expression and activity of nitric oxide synthases in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 16:629-639.
27. Liu, S.F., E.B. Haddad, I. Adcock, M. Salmon, H. Koto, T. Gilbey, P.J. Barnes, and K.F. Chung. 1997. Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung. Br. J. Pharmacol. 121:1241-1246.
28. Yates, D.H., S.A. Kharitonov, P.S. Thomas, and P.J. Barnes. 1996. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 154:247-250.
29. De Sanctis, G.T., S. Mehta, L. Kobzik, C. Yandava, A. Jiao, P.L. Huang, and J.M. Drazen. 1997. Contribution of type I NOS to expired gas NO and bronchial responsiveness in mice. Am. J. Physiol. 273:L883-L888.
30. Tucker, J.F., S.R. Brave, L. Charalambous, A.J. Hobbs, and A. Gibson. 1990. L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br. J. Pharmacol. 100:663-664.
31. Li, C.G., and M.J. Rand. 1991. Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br. J. Pharmacol. 102:91-94.
32. Feder, L.S., D. Stelts, R.W. Chapman, D. Manfra, Y. Crawley, H. Jones, M. Minnicozzi, X. Fernandez, T. Paster, R.W. Egan, et al. 1997. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am. J. Respir. Cell Mol. Biol. 17:436-442.
33. Hierholzer, C., B. Harbrecht, J.M. Menezes, J. Kane, J. MacMicking, C.F. Nathan, A.B. Peitzman, T.R. Billiar, and D.J. Tweardy. 1998. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 187:917-928.
34. Khan, I.A., T. Matsuura, and L.H. Kasper. 1998. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161: 2994-3000.
35. Barnes, K.C., J.D. Neely, D.L. Duffy, L.R. Freidhoff, D.R. Breazeale, C. Schou, R.P. Naidu, P.N. Levett, B. Renault, R. Kucherlapati, et al. 1996. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and Caucasian populations. Genomics. 37:41-50.
36. Thomas, N.S., J. Wilkinson, and S.T. Holgate. 1997. The candidate region approach to the genetics of asthma and allergy. Am. J. Respir. Crit. Care Med. 156:S144-S151.
37. The Collaborative Study on the Genetics of Asthma (CSGA). 1997. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat. Genet. 15:389-392.
38. Huang, P.L., T.M. Dawson, D.S. Bredt, S.H. Snyder, and M.C. Fishman. 1993. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1273-1286.
39. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Sevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
40. Son, H., R.D. Hawkins, K. Martin, M. Kiebler, P.L. Huang, M.C. Fishman, and E.R. Kandel. 1996. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1015-1023.
41. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650. (See published erratum 81(7):following 1170.)
42. MacLean, J.A., A. Sauty, A.D. Luster, J.M. Drazen, and G.T. De Sanctis. 1999. Antigen-induced airway hyperresponsive-ness, pulmonary eosinophilia and chemokine expression in B cell-deficient mice. Am. J. Respir. Cell Mol. Biol. 20:379-387.
43. Scott, J.A., M. Machoun, and D.G. McCormack. 1996. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. J. Appl. Physiol. 80: 271-277.
44. De Sanctis, G.T., M. Merchant, D.R. Beier, R.D. Dredge, J.K. Grobholz, T.R. Martin, E.S. Lander, and J.M. Drazen. 1995. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat. Genet. 11:150-154.
45. De Sanctis, G.T., A. Itoh, F.H. Green, S. Qin, T. Kimura, J.K. Grobholz, T.R. Martin, T. Maki, and J.M. Drazen. 1997. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 3:460-462.
46. Martin, T.R., N.P. Gerard, S.J. Galli, and J.M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318-2323.
47. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G.L. Larsen, C.G. Irvin, and E.W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766-775.
48. Corry, D.B., G. Grunig, H. Hadeiba, V.P. Kurup, M.L. Warnock, D. Sheppard, D.M. Rennick, and R.M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4:344-355.
49. Strath, M., D.J. Warren, and C.J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods. 83:209-215.
50. Barnes, P.J. 1995. Nitric oxide and airway disease. Ann. Med. 27:389-393.
51. Gaston, B., S. Sears, J. Woods, J. Hunt, M. Ponaman, T. McMahon, and J.S. Stamler. 1998. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet. 351: 1317-1319.
52. Krinzman, S.J., G.T. De Sanctis, M. Cernadas, D. Mark, Y. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, et al. 1996. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98:2693-2699.
53. Persson, M.G., O. Zetterstrom, V. Agrenius, E. Ihre, and L.E. Gustafsson. 1994. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 343:146-147.
54. Kharitonov, S.A., D.H. Yates, and P.J. Barnes. 1996. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153:454-457.
55. Xiong, Y., G. Karupiah, S.P. Hogan, P.S. Foster, and A.J. Ramsay. 1999. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J. Immunol. 162:445-452.
56. Lambert, L.E., J.S. Berling, and E.M. Kudlacz. 1996. Characterization of the antigen-presenting cell and T cell requirements for induction of pulmonary eosinophilia in a murine model of asthma. Clin. Immunol. Immunopathol. 81:307-311.
57. Kung, T.T., H. Jones, G.K. Adams III, S.P. Umland, W. Kreutner, R.W. Egan, R.W. Chapman, and A.S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
58. Krinzman, S.J., G.T. De Sanctis, M. Cernadas, L. Kobzik, J.A. Listman, D.C. Christiani, D.L. Perkins, and P.W. Finn. 1996. T cell activation in a murine model of asthma. Am. J. Physiol. 271:L476-L483.
59. MacLean, J.A., A. Sauty, A.D. Luster, J.M. Drazen, and G.T. De Sanctis. 1999. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am. J. Respir. Cell Mol. Biol. 20:379-387.
60. Zuany-Amorim, C., C. Ruffie, S. Haile, B.B. Vargaftig, P. Pereira, and M. Pretolani. 1998. Requirement for γδ T cells in allergic airway inflammation. Science. 280:1265-1267.